Why PRQR Stock And APOP Stock Are Popping Off Today

ProQR Therapeutics NV PRQR shares are trading higher by more than 52% after the company reported results Wednesday from its trial of QR-421a in Usher Syndrome, though the stock did not surge initially.

ProQR is a biopharmaceutical company that develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber's congenital amaurosis type 10 and dyastrophic epidermolysis bullosa.

Cellect Biotechnology Ltd - ADR APOP shares are trading higher after the company and Quoin Pharmaceuticals announced a strategic merger.

Cellect is a biotechnology company that has developed a novel technology platform known as ApoGraft that functionally selects cells in order to improve the safety and efficacy of regenerative medicine and cell therapies.